RIVM publishes Mucuna pruriens safety advice
Safety context is added to the evidence ledger. It is not represented as a 2026 recall decision.
Open source ↗

EU + POLAND EVIDENCE PROFILE
A botanical where the non-binding EU status signal and the 2026 Dutch product recalls must be recorded as different evidence types, then checked across direct ingredients and blends.
IDENTITY BEFORE STATUS
CLAIMS
This page does not identify a product-ready authorised EU health claim for Mucuna pruriens or levodopa.
RESTRICTIONS
Resolve the exact ingredient identity in every formula and blend; a product name may not disclose that Mucuna is present.
Treat the Novel Food Catalogue as orientation only. Verify Union-list status, any applicant-specific route, national interpretation and the actual recall notice before a legal or operational decision.
The RIVM safety assessment reports that a safe dose could not be established from the available public evidence and provides precautionary advice for defined groups.
A Dutch recall notice does not automatically establish the same enforcement action, scope or deadline in another EU market.
STATUS → ENFORCEMENT → RECALLS
Safety context is added to the evidence ledger. It is not represented as a 2026 recall decision.
Open source ↗Distributor records name multiple direct-ingredient products and state an all-batch scope for the listed EANs.
Open source ↗Retailer notices include Ortho Multi Man, showing why formula-level identity resolution must go beyond the product title.
Open source ↗Suppvera records the Commission Catalogue as non-binding context and the named notices as event evidence; neither automatically creates an EU-wide stop-sale decision.
Open source ↗A status interpretation and a product recall are stored as different evidence classes. This timeline does not create an EU-wide prohibition or execute a stop-sale action.
POLISH NOTES
For Poland, perform a separate product-level Novel Food, ingredient, medicinal-presentation, claims and notification review; the Dutch notices are evidence of enforcement activity, not a Polish decision.
Keep supplier specification, plant part, extraction, L-Dopa assay, daily portion and blend composition linked to the exact SKU and batch.
PRIMARY SOURCES
Status orientation only; non-exhaustive and not recall evidence
Seed-extract safety context and uncertainty
Named products, EANs and all-batch recall scope
Direct and multi-ingredient products including Ortho Multi Man